Natural flavonoid sinensetin inhibits cisplatin-induced pyroptosis and attenuates intestinal injury

Biochim Biophys Acta Mol Basis Dis. 2023 Mar;1869(3):166637. doi: 10.1016/j.bbadis.2023.166637. Epub 2023 Jan 10.

Abstract

The demand of exploring strategies to enhance chemotherapy drug efficacy and alleviate adverse effects by using natural compounds is increasing. Sinensetin (SIN) is a kind of natural flavonoids with anti-inflammatory activities. However, its protective impact on chemotherapy-induced adverse effects has not been well demonstrated. Here, we found that SIN could inhibit Cisplatin-induced release of proinflammatory cellular contents and inflammatory cell death-pyroptosis. In addition, Cisplatin-induced activation of gasdermin E (GSDME), a critical mediator of chemotherapy-induced tissue injury, could also be reversed by SIN. Furthermore, SIN impaired Cisplatin-induced intracellular damages, including ROS release and DNA damages. Importantly, SIN was able to alleviate intestinal injury in Cisplatin-challenged mice, which was accompanied by the decrease of lytic cell death and immune cell infiltration. Of note, SIN administration did not reverse Cisplatin-caused tumor suppression in vivo. In conclusion, our result provides a potential application of SIN to reduce Cisplatin-caused adverse effects, without impairing its anti-tumor capacity.

Keywords: Adverse effects; Chemotherapy; Pyroptosis; Sinensetin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents* / pharmacology
  • Cisplatin* / adverse effects
  • Flavonoids / pharmacology
  • Flavonoids / therapeutic use
  • Mice
  • Pyroptosis

Substances

  • Cisplatin
  • sinensetin
  • Flavonoids
  • Antineoplastic Agents